Aaron Delahanty is an Associate with Anzu Partners and a Biomedical Engineer with experience in product development and commercialization.
Previously, Aaron was part of the Advanced Technology Team at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he was responsible for the management of the microengineering group. Aaron also has substantial industry experience with early to mid-stage start-ups as well as large multinational corporations. During his role at biotech start-up Rheonix, he was part of the product development team that guided molecular diagnostic instrumentation from early-stage prototype to commercially available product. His areas of technical expertise lie within microfluidics, lab-on-chip technology, nanofabrication and systems engineering. His academic research focused on the control of break-up dynamics in microfluidic droplets and microcapsules, resulting in patented technology.
Aaron Delahanty received his BSc in Mechanical Engineering from Rochester Institute of Technology and his MSc in Biomedical Engineering from University of Glasgow.